1. ‘Genotropin’ labelling updated

   News item 02 February 2013 Pages: 2 - 2

2. ADR monitoring in Finland, 1973−2002

   Comment 02 February 2013 Pages: 2 - 2

3. Topiramate: Canadians advised of label update

   News item 02 February 2013 Pages: 2 - 2

4. High-dose aspirin plus ACE inhibitors increase mortality

   Clinical study 02 February 2013 Pages: 3 - 3

5. Risk factors for spironolactone-associated hyperkalaemia

   Clinical study 02 February 2013 Pages: 3 - 3

6. Salmeterol ‘safe’ for use in COPD?

   Clinical study 02 February 2013 Pages: 3 - 3

7. Tocopherol, β-carotene and cancer: ATBC study follow-up

   Clinical study 02 February 2013 Pages: 3 - 3

8. Artemether: no evidence of neurotoxic effects

   Clinical study 02 February 2013 Pages: 4 - 4

9. Breast cancer risk following Hodgkin’s disease treatment

   News item 02 February 2013 Pages: 4 - 4

10. High-dose sildenafil effective for ejaculatory delay?

    Clinical study 02 February 2013 Pages: 5 - 5

11. Human studies support safety of cimicifuga

    Incidence study 02 February 2013 Pages: 5 - 5

12. Risk factors for recurrent post-ablation AF

    Clinical study 02 February 2013 Pages: 5 - 5

13. Antipsychotics

    Case report 02 February 2013 Pages: 6 - 6

14. Aspirin

    Case report 02 February 2013 Pages: 6 - 6

15. Atropine

    Case report 02 February 2013 Pages: 6 - 6

16. BCG vaccine

    Case report 02 February 2013 Pages: 6 - 6

17. Bupropion

    Case report 02 February 2013 Pages: 6 - 6

18. Ceftriaxone

    Case report 02 February 2013 Pages: 6 - 6

19. Ceftriaxone

    Case report 02 February 2013 Pages: 7 - 7

20. Citalopram

    Case report 02 February 2013 Pages: 7 - 7

21. Citalopram/fluoxetine

    Case reports 02 February 2013 Pages: 7 - 7

22. Clindamycin

    Case reports 02 February 2013 Pages: 7 - 7

23. Clozapine

    Case reports 02 February 2013 Pages: 7 - 8

24. Dacarbazine/doxorubicin

    Case report 02 February 2013 Pages: 8 - 8

25. Ergotamine interaction

    Case report 02 February 2013 Pages: 8 - 8

26. Fluorouracil

    Case reports 02 February 2013 Pages: 8 - 8

27. Ginkgo biloba/ibuprofen

    Case report 02 February 2013 Pages: 8 - 9

28. Hyaluronan membrane

    Case reports 02 February 2013 Pages: 9 - 9

29. Hyaluronidase

    Case report 02 February 2013 Pages: 9 - 9

30. Hydrochlorothiazide

    Case report 02 February 2013 Pages: 9 - 9

31. Hydroxycarbamide

    Case report 02 February 2013 Pages: 9 - 9

32. Hydroxycarbamide/pipobroman

    Case report 02 February 2013 Pages: 9 - 10

33. Ibuprofen

    Case report 02 February 2013 Pages: 10 - 10

34. Immunoglobulins

    Case reports 02 February 2013 Pages: 10 - 10

35. Infliximab

    Case report 02 February 2013 Pages: 10 - 10

36. Insulin

    Case report 02 February 2013 Pages: 10 - 10

37. Latanoprost

    Case report 02 February 2013 Pages: 11 - 11

38. Methadone withdrawal

    Case reports 02 February 2013 Pages: 11 - 11

39. Mirtazapine

    Case report 02 February 2013 Pages: 11 - 11

40. Morphine

    Case report 02 February 2013 Pages: 11 - 11

41. Olanzapine

    Case report 02 February 2013 Pages: 12 - 12

42. Olanzapine

    Case report 02 February 2013 Pages: 12 - 12

43. Paclitaxel

    Case report 02 February 2013 Pages: 12 - 12

44. Paracetamol/codeine

    Case reports 02 February 2013 Pages: 12 - 12

45. Phenytoin overdose

    Case report 02 February 2013 Pages: 12 - 12

46. Povidone iodine

    Case report 02 February 2013 Pages: 12 - 13

47. Povidone iodine

    Case report 02 February 2013 Pages: 13 - 13

48. Pramipexole

    Case report 02 February 2013 Pages: 13 - 13

49. Raltitrexed

    Case report 02 February 2013 Pages: 13 - 13

50. Ranitidine

    Case reports 02 February 2013 Pages: 13 - 13